ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 19 of 39
Up
JMBS 2017, 2(6): 90–95
https://doi.org/10.26693/jmbs02.06.090
Clinical Medicine

Correlation between the Types of Myoma and the Pathological Process

Magdenko A. K. 1, Savytskyi I. V. 2, Zelynskyi O. O. 2, Miastkivska I. V. 2, Hryhoriev P. Y. 3
Abstract

Today myoma of the uterus is one of the most common pathologies of female reproductive system. According to one source, the rate of the disease varies in 20-25% of women of the reproductive age, according to other sources - from 40 to 60%. Separate researches represent that the rate of this disease may reach 70-80%. Previously it was considered that myoma is the diagnosis of females older than 35, nevertheless lately this pathology is found in women under 20-25, who have not realized their reproductive function yet, more and more often, including the ones without any sexual experience. In the case of myoma significant enlargement it leads to the disorder of functioning of the pelvis organs, pain syndrome and it is the reason of abnormal menstrual and intermenstrual hemorrhages. Severe symptoms may occur in 15-30% of cases, while the severity of symptoms depends on the localization, amount and sizes of the nodes. Myoma of the uterus may also give no symptoms. It is well-known that myoma of the uterus does not only lead to infertility (from 5 tj 10% of cases are related to the uterine myoma), but also it leads to miscarriages, complications during childbirth and postpartum period. One of less frequent, but still life-threatening for the patients, complications of the uterine myomas progressing is hemoperitoneum, which occurs as the result of hemodynamic instability and requires immediate surgical intervention. There is a big variety of different data about the factors of myoma of the uterus and its symptoms in literature, some of them are disunited and controversial. Materials and methods: A retrospective analysis of 80 case histories of patients with a confirmed diagnosis of myoma of the uterus (with submucosal, subserous and intramural uterine myoma according to ICD-10/ C00-D48 / D10-D36 / D25) admitted to the hospital for hysteroscopy, fractional-diagnostic curettage. The complex index of disease severity was calculated as follows. Each of the variables - the number of nodes, the size of the nodes (small nodes – up to 2 cm, medium – 2 to 6 cm, large – more than 6 cm (according to the classification of Tykhomirov), and the type of fibroids accordingly gradations of its unfavorability for a woman's condition and risk of malignancy (from subserous to submucous) – were given a scale of standard deviations – that is, they were standardized to lead to a single scale. Results. The greatest number of significant links of the status indicators of a woman with the objective parameters of the disease chosen by us (the number of nodes, the size of the node, the type of uterine fibroids, a complex index per listed in three parameters) turns out to be for the type of uterine fibroids (subserous, intramural and submucous). It is an important result that this kind of indicator does not carry new information, and to analyze the connection severity of the disease follows the correlation of the patient's status indicators with each of the objective parameters of the severity of the diagnosis of patients as a result of all sorts of these dependencies. Discussion: The largest positive connections received with complaints of infertility, as well as the localization of nodes on the uterine fundus with patients with submucous myoma of the uterus. The most common location of myomatous nodes is on the anterior and posterior walls. The associated abundant discharge and increasing blood loss during the menstrual period also depend on the number of nodes. Taking into account the above-said, we came to the conclusion that the complex indicator of the severity of the diagnosis does not carry new information. To analyze the connection of the disease severity we follow the correlation of the patient's status indicators with each of the objective parameters of the severity of the diagnosis due to various kinds of these dependencies.

Keywords: uterine myoma, gamma-correlation, subserous nodes, submucous nodes, intramural nodes

Full text: PDF (Ukr) 195K

References
  1. Barri-Soldevila PN, Vázquez A. Current role of conservative surgery. Med Clin (Barc). 2013 Jul; 141 (1): 7-12. https://doi.org/10.1016/S0025-7753(13)70046-0.
  2. Bashmakova NV, Roshchina MO, Chistyakov MA. Otsenka gistologicheskikh i immunogistokhimicheskikh izmeneniy v endometrii posle provedeniya embolizatsii matochnykh arteriy po povodu miomy matki. Akusherstvo i ginekologiya. 2012; 8-1: 20-4. [Russian].
  3. Benson CB, Chow JS, Chang-Lee W, Hill JA 3rd, Doubilet PM. Outcome of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester. J Clin Ultrasound. 2001; 29: 261-4. https://www.ncbi.nlm.nih.gov/pubmed/11486319. https://doi.org/10.1002/jcu.1031
  4. Borah BJ, Nicholson WK, Bradley L, Stewart EA. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013; 209: 319.e1–319.e20. https://www.ncbi.nlm.nih.gov/pubmed/23891629. https://www.ncbi.nlm.nih.gov/pmc/articles/4167669. https://doi.org/10.1016/j.ajog.2013.07.017
  5. Cañete Palomo ML, Martín NR. Management of fibroids. Med Clin (Barc). 2013 Jul; 141 (1): 55-61. https://www.ncbi.nlm.nih.gov/pubmed/24314569. https://doi.org/10.1016/S0025-7753(13)70054-X.
  6. Casini ML, Rossi F, Agostini R, Unfer V. Effects of the position of fibroids on fertility. Gynecol Endocrinol. 2006; 22: 106-9. https://www.ncbi.nlm.nih.gov/pubmed/16603437. https://doi.org/10.1080/09513590600604673
  7. Cerruto E, Sudano MC, Ettore C, La Greca G, La Greca MG. Difficult diagnosis of hemoperitoneum in a patient with a pelvic mass of large size. Int J Surg Case Rep. 2016; 26: 197-8. https://www.ncbi.nlm.nih.gov/pubmed/27497942. https://www.ncbi.nlm.nih.gov/pmc/articles/4975705. https://doi.org/10.1016/j.ijscr.2016.07.040
  8. Dzhakupov DV, Lokshin VN, Khamko VA. Patogeneticheskie osobennosti izmeneniya morfologicheskoy struktury pri miome matki, oslozhnennoy krovotecheniem. Vestnik Novgorodskogo gosudarstvennogo universiteta. 2014; 78: 122-4. [Russian].
  9. Grebennikova EK, Tskhay VB, Medvedeva NN. Konstitutsionalnye osobennosti zhenshchin s giperplasticheskimi zabolevaniyami matki. Sibirskoe meditsinskoe obozrenie. 2012; 4: 34-6. [Russian].
  10. Havryliuk Y, Setton R, Carlow JJ, Shaktman BD. Symptomatic Fibroid Management: Systematic Review of the Literature. JSLS. 2017 Jul-Sep; 21 (3): e2017.00041. https://www.ncbi.nlm.nih.gov/pubmed/28951653. https://www.ncbi.nlm.nih.gov/pmc/articles/5600131. https://doi.org/10.4293/JSLS.2017.00041
  11. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008; 198: 357–66. https://www.ncbi.nlm.nih.gov/pubmed/18395031. https://doi.org/10.1016/j.ajog.2007.12.039.
  12. Kondratovich LM. Sovremennyy vzglyad na etiologiyu, patogenez i sposoby lecheniya miomy matki. Rossiyskiy meditsinskiy zhurnal. 2014; 5: 36-40. [Russian].
  13. Lee HJ, Norwitz ER, Shaw J. Contemporary management of fibroids in pregnancy. Rev Obstet Gynecol. 2010; 3: 20-7. https://www.ncbi.nlm.nih.gov/pubmed/20508779. https://www.ncbi.nlm.nih.gov/pmc/articles/2876319
  14. Pérez-López FR, Ornat L, Ceausu I, Depypere H, Erel CT, Lambrinoudaki I, Schenck-Gustafsson K, et al. EMAS position statement: management of uterine fibroids. Maturitas. 2014 Sep; 79 (1): 106-16. https://www.ncbi.nlm.nih.gov/pubmed/24975954. https://doi.org/10.1016/j.maturitas.2014.06.002.
  15. Pritts EA, Parker WH, Olive DL. Fibroids and Infertility: an updated systematic review of the literature. Fertil Steril. 2009; 91: 1215-23. https://www.ncbi.nlm.nih.gov/pubmed/18339376. https://doi.org/10.1016/j.fertnstert.2008.01.051
  16. Tajima S, Yonezawa I, Waki M, Hoshi S. Massive hemoperitoneum following spontaneous rupture of an arterial aneurysm overlying a uterine myoma. Int J Clin Exp Med. 2015; 8: 3002-5. https://www.ncbi.nlm.nih.gov/pubmed/25932272. https://www.ncbi.nlm.nih.gov/pmc/articles/4402919
  17. Tikhomirov AL, Lubnin DM. Mioma matki. Moskva: MIA; 2006. 176 s. [Russian].
  18. Tolstolutskaya EA, Tetelyutina FK, Soloveva ME, Meytis OI, Klestov KB. Differentsialnyy podkhod k lecheniyu miomy matki. Meditsinskiy almanakh. 2010; 3: 91-2. [Russian].
  19. Vergani P, Locatelli A, Ghidini A, Andreani M, Sala F, Pezzullo JC. Large uterine leiomyomata and risk of cesarean delivery. Obstet Gynecol. 2007; 109: 410–4. https://www.ncbi.nlm.nih.gov/pubmed/17267843. https://doi.org/10.1097/01.AOG.0000250470.78700.f0
  20. Volkova LV, Alyautdina OS. Kliniko-diagnosticheskoe znachenie sosudisto-endotelialnogo faktora rosta pri neudachnykh popytkakh EKO. Akusherstvo i ginekologiya. 2011; 4: 123-9. [Russian].